SCHEMBL5513768

SCHEMBL5513768

CC(C)[C@H](C(=O)N(C)CCO)C(C)(C)C

nearest known ligand 0.39

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
CHRNB2 P17787 1/20 0.39
CHRNB4 P30926 1/20 0.39
CHRNA3 P32297 1/20 0.39
CHRNA4 P43681 1/20 0.39
DPP4 P27487 3/20 0.33
KDM4E B2RXH2 1/20 0.33
ATM Q13315 1/20 0.33
MAPT P10636 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14679301 0.82 CHRNB2 (0.40) CHRNB2CHRNB4CHRNA3CHRNA4DPP4
SCHEMBL5515622 0.82 MLYCD (0.30) DPP4
SCHEMBL13821860 0.79 DPP4 (0.35) DPP4
SCHEMBL14679290 0.77 CHRNB2 (0.42) CHRNB2CHRNB4CHRNA3CHRNA4DPP4
SCHEMBL19308262 0.77 CHRNB2 (0.42) CHRNB2CHRNB4CHRNA3CHRNA4DPP4
SCHEMBL5514707 0.77 CHRNB2 (0.42) CHRNB2CHRNB4CHRNA3CHRNA4DPP4
SCHEMBL4546666 0.76 CHRNB2 (0.44) CHRNB2CHRNB4CHRNA3CHRNA4DPP4
SCHEMBL2746323 0.76 DPP4 (0.58) CHRNB2CHRNB4CHRNA3CHRNA4DPP4
SCHEMBL26535305 0.74 CHRNB2 (0.43) CHRNB2CHRNB4CHRNA3CHRNA4DPP4
SCHEMBL2745900 0.73 DPP4 (0.56) CHRNB2CHRNB4CHRNA3CHRNA4DPP4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8367666-B2 3-carbamoyl-2-pyridone derivatives SHIONOGI & CO., LTD. (JP) 2013-02-05 US disclosed
US-8178681-B2 methyl 3-methyl-2-{[2-oxo-1-(2-oxo-ethyl)-1,2,5,6,7,8,9,10-octahydro-cycloocta[b]pyridine-3-carbonyl]-amino}-butyrate; cannabinoid receptor agonist; antiinflammatory agent, immunostimulant, analgesic; atopic dermatitis; excellent in photostability, and have excellent transdermal and oral absorbency SHIONOGI & CO., LTD. (JP) 2012-05-15 US disclosed
US-8178681-B2 methyl 3-methyl-2-{[2-oxo-1-(2-oxo-ethyl)-1,2,5,6,7,8,9,10-octahydro-cycloocta[b]pyridine-3-carbonyl]-amino}-butyrate; cannabinoid receptor agonist; antiinflammatory agent, immunostimulant, analgesic; atopic dermatitis; excellent in photostability, and have excellent transdermal and oral absorbency SHIONOGI & CO., LTD. (JP) 2012-05-15 US disclosed